Optimal response-adaptive designs for normal responses
From MaRDI portal
Recommendations
- Optimal response-adaptive designs for continuous responses in phase III trials
- A new response-adaptive design for continuous treatment responses for phase III clinical trials
- Multi-treatment optimal response-adaptive designs for phase III clinical trials
- Kernel-Based Response-Adaptive Design for Continuous Responses
- Optimal adaptive designs for binary response trials
Cited in
(9)- Optimal responses-adaptive designs based on efficiency, ethic, and cost
- A new response-adaptive design for continuous treatment responses for phase III clinical trials
- Optimal response-adaptive designs for continuous responses in phase III trials
- An optimal allocation for response-adaptive designs
- Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality
- Implementing optimal allocation in clinical trials with multiple endpoints
- Multi-treatment optimal response-adaptive designs for phase III clinical trials
- An optimal response-adaptive design with dual constraints
- A randomized two stage allocation for continuous response clinical trials
This page was built for publication: Optimal response-adaptive designs for normal responses
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5123164)